SubscribeThe use of high throughput screening for discovery of new kinase inhibitors is a fundamental approach being pursued for many diseases.
- Transcreener™ KINASE ASSAY kits are far-red, competitive FP immunoassay
based on the detection of ADP - Transcreener™ can monitor any enzymatic reaction that used ATP,
with an ATP concentration range of 1 to 250 mM - The PHERAstar is a multifunctional HTS microplate reader
with unmatched speed, sensitivity and ease-of-use
Conventional Kinase HTS Assays
Rely on detection methods specific for a single phosphorylated product. This is problematic in that each of the many kinase subfamilies must then have it's own unique set of assay reagents,
specifically optimized. To eliminate these difficulties, BellBrook Labs has developed the universal Transcreener™ KINASE Assay, a homogeneous, competitive fluorescent polarization HTS assay that directly detects ADP, the invariant reaction product of all kinase reactions. A single set of reagents, which includes a novel anti-ADP antibody and a far red ADP-Alexa Fluor® 633 tracer, can be used to assay across the entire protein kinase family as well as the lipid kinase and carbohydrate kinase families. Rapid generation of meaningful and comparable data is
obtained using standardized assay methodologies and data analyses. The Transcreener™ KINASE Assay is not dependent on a modified acceptor substrate, and therefore is not limited to use with kinases, but can be used to assay any ADP-producing enzyme, including ATPases, carboxylases, and helicases. Likewise, the assay can be easily optimized to accommodate a range of ATP concentrations. (1)
BMG LABTECH’s PHERAstar
Is a multifunctional microplate reader that combines rapid plate reading necessary for HTS with enhanced performance and sensitivity needed to read small fluid volumes. The PHERAstar reads all HTS detection modes (fluorescence intensity, time-resolved fluorescence, fluorescence polarization, luminescence, Alphascreen™, and absorbance) in all plate formats up to 1536 wells. The PHERAstar uses a unique application-specific module in conjunction with an optical reading head featuring five photomultiplier tubes that can simultaneous measure two emission signals at any desired wavelength. This optical design provides for outstanding sensitivity and accuracy in fluorescence and luminescence assays, and the simultaneous measurement minimizes the read time.
Assay Principle
The Transcreener™ KINASE assay is a fluorescence polarization immunoassay based on the detection of ADP by an antibody (Figure 1).
This assay platform provides the possibility to universally interrogate cell enzymes that catalyze group transfer reactions with ATP. In step one of the assay, kinases catalyze the transfer of phosphate from ATP to a protein, peptide, lipid or small molecule resulting in the accumulation of ADP.
Fig. 1: Transcreener Assay Principle for Kinases
In step two the Transcreener™ ADP Detection Mixture, which contains an ADP Alexa Fluor 633® tracer bound to an anti-ADP antibody, is added. If there is enzymatic activity resulting in necessary ADP then the bound tracer is displaced by the ADP. The free tracer rotates quickly leading to a lower polarization value. If there is no free ADP because of no enzymatic activity, the tracer is still bound to the antibody. This whole construct rotates very slowly giving a higher polarization number. Therefore, ADP production is proportional to a decrease in fluorescence polarization.
Materials and Methods
All materials were obtained through normal distribution channels from the manufacturers stated.
- 96 well and 384 well small volume, black microplates from Greiner Bio-One, Frickenhausen, Germany
- Transcreener™ Kinase Assay from BellBrook Labs, Madison, WI, Cat.No. 3003-1K (including ADP Far Red Tracer, ADP Antibody, Stop and Detect Buffer, ADP)
- Adenosine triphosphate (ATP) purchased from Sigma-Aldrich, Taufkirchen, Germany
- PHERAstar, BMG LABTECH, Offenburg, Germany (Figure 2)
- Thermostar, BMG LABTECH, Offenburg, Germany
Fig. 2: BMG LABTECH’s PHERAstar - Multifunctional HTS microplate reader
Using 100 µM ADP and 100 µM ATP stock solutions a 15 point ADP/ATP standard curve was prepared, while keeping a constant concentration of total adenosine. This standard curves mimics a kinase or ATPase reaction (Note ADP is produced while ATP is depleted). The upper limit of the standard curve was set to 0 µM ADP/100 µM ATP (mimicking 0% conversion) and the lower limit was set to 100 µM ADP/0 µM ATP (mimicking 100 % conversion).
To the different ADP/ATP solutions the same volume of ADP Detection Mixture was pipetted into the microplate containing the suitable amount of antibody (for more details please refer to the assay protocol 1). The solutions (96-well final volume 300 µl, 384-well SV final volume 20 µl) were mixed and incubated for 1 hour at room temperature.
The fluorescence polarization measurements were done using a Transcreener™ specific FP optical module with Excitation at 590 nm and Emission A (parallel) and Emission B (perpendicular) at 675 nm. The mP target was set to 200 mP for the highest ATP concentration.
Results
Figure 3 and figure 4 show the standard curves measured on the PHERAstar in 96 well and 384 well format, respectively. Graphing on the log scale eliminates the point that corresponds to zero. To include all fifteen points along the curve, the value for 0 µM ADP/100 µM ATP was graphed at 0.02 µM position.
Fig. 3: ATP/ADP standard curve perfomed in a 96 well microplate.
Fig. 4: ATP/ADP standard curve perfomed in a 384 well microplate.
Both graphs show similar ranges and also similar EC50 values indicating that the Transcreener™ Kinase FP assay can be performed on the PHERAstar using both plate types.
In order to show that there is no significant well to well variation, 20 replicates of the upper and lower limit of the standard curve were measured in a 384-well small volume plate (Figure 5).
Fig. 5: Transcreener FP values for 20 replicates for the upper limit (blue diamonds) and the lower limit (red squares) of standard curve
Figure 5 shows the high consistency of well to well measurements when using the PHERAstar for the Transcreener FP assay. The resulting CVs (< 1 %CV for the upper limit and < 3 %CV for the lower limit of standard curve) also demonstrate consistent measurements. From these data, a representative Z´value of 0.89 was calculated.
Conclusion
The universally generic nature of the Transcreener ASSAY kit will reduce assay development efforts thus allowing HTS to occur earlier.
As a characteristic parameter for the quality of the assay, a Z′value of 0.89
was calculated, which represents an excellent assay performance. Z′values between 0.5 and 1 indicate a highly robust screening assay and reflect high quality of instrumentation (2).
BMG LABTECH’s PHERAstar microplate reader provides the ideal platform to simplify the Transcreener™ KINASE assay. With its dual wavelength emission detection and five photomultiplier tubes (PMTs), the PHERAstar provides the speed and sensitivity needed to take full advantage of BellBrook Labs Transcreener™ technology. Furthermore, BMG has designed an optic module specifically for BellBrook Labs’ Transcreener™, thereby making assay setup simple.
References
1 Transcreener™ KINASE Assay Technical Manual, BellBrook Labs, Madison WI. http://www.bellbrooklabs.com/pdf_files/BBL%20Protocol_KINASEplus_easyread.pdf.
2 Zhang J et al.: (1999) J.Biomol.Screen. 4, 67-73.